The Board of Directors approved Audited Standalone Financial Results for the quarter & year ended 31.03.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Chemiesynth (Vapi) Ltd approved audited standalone financial results for the quarter and year ended March 31, 2025. Full-year revenue from operations rose about 15% to ₹1,888.71 lakhs from ₹1,643.35 lakhs in FY24, while Q4 revenue jumped roughly 50% to ₹668.45 lakhs. The company posted a net loss of ₹10.62 lakhs for FY25, a sharp improvement from the ₹38.82 lakh loss in FY24, and Q4 turned profitable at ₹18.86 lakhs versus a ₹20.12 lakh loss a year earlier. EPS for FY25 was -₹0.35 compared with -₹1.26 in the previous year. Operating cash flow swung to a healthy positive ₹264.76 lakhs (vs negative ₹2.57 lakhs in FY24). Statutory auditor Manoj Shah & Co. issued an unmodified (clean) opinion on the results.
The narrowing losses, Q4 return to profitability, and strong operating cash flow turnaround are encouraging signs for shareholders, though the company remains in the red for the full year. A clean audit opinion removes near-term governance concerns, but the stock may remain range-bound until sustained profitability is demonstrated.